Samuel Richard Schnittman, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytomegalovirus Infections | 3 | 2024 | 837 | 1.130 |
Why?
|
| HIV Infections | 8 | 2024 | 17569 | 0.720 |
Why?
|
| Hepatitis B Vaccines | 1 | 2021 | 178 | 0.680 |
Why?
|
| Aortic Valve | 3 | 2018 | 1970 | 0.640 |
Why?
|
| Heart Valve Prosthesis Implantation | 2 | 2017 | 1566 | 0.550 |
Why?
|
| Bioprosthesis | 2 | 2017 | 593 | 0.520 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2024 | 1815 | 0.520 |
Why?
|
| Labor, Induced | 1 | 2017 | 156 | 0.520 |
Why?
|
| Immune System | 1 | 2021 | 799 | 0.510 |
Why?
|
| Adjuvants, Immunologic | 1 | 2021 | 998 | 0.500 |
Why?
|
| Hepatitis B | 1 | 2021 | 711 | 0.500 |
Why?
|
| Pulmonary Valve | 1 | 2017 | 413 | 0.430 |
Why?
|
| Heart Valve Prosthesis | 3 | 2018 | 1468 | 0.410 |
Why?
|
| Mitral Valve | 2 | 2017 | 1475 | 0.390 |
Why?
|
| Choice Behavior | 1 | 2017 | 848 | 0.370 |
Why?
|
| Macrophages | 2 | 2024 | 5799 | 0.340 |
Why?
|
| Postoperative Care | 1 | 2016 | 1480 | 0.340 |
Why?
|
| Cytomegalovirus | 3 | 2024 | 753 | 0.330 |
Why?
|
| Aortic Valve Stenosis | 2 | 2018 | 2032 | 0.300 |
Why?
|
| Hemorrhage | 1 | 2017 | 3467 | 0.240 |
Why?
|
| Anti-HIV Agents | 1 | 2021 | 4573 | 0.240 |
Why?
|
| HIV-1 | 1 | 2021 | 6961 | 0.220 |
Why?
|
| California | 2 | 2017 | 1438 | 0.210 |
Why?
|
| Coronary Artery Disease | 1 | 2023 | 6568 | 0.210 |
Why?
|
| Heart Transplantation | 1 | 2016 | 3301 | 0.200 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2021 | 75 | 0.190 |
Why?
|
| Kynurenine | 1 | 2021 | 142 | 0.180 |
Why?
|
| Prosthesis Design | 2 | 2017 | 2125 | 0.170 |
Why?
|
| Chemokine CXCL10 | 1 | 2021 | 311 | 0.170 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2021 | 283 | 0.170 |
Why?
|
| Arteries | 1 | 2024 | 1127 | 0.160 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2021 | 348 | 0.160 |
Why?
|
| Tryptophan | 1 | 2021 | 482 | 0.160 |
Why?
|
| HIV | 2 | 2023 | 1597 | 0.160 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 15662 | 0.140 |
Why?
|
| Rheumatic Heart Disease | 1 | 2017 | 164 | 0.130 |
Why?
|
| Mitral Valve Annuloplasty | 1 | 2017 | 145 | 0.130 |
Why?
|
| Postoperative Complications | 2 | 2018 | 15832 | 0.130 |
Why?
|
| Stroke | 1 | 2017 | 9755 | 0.120 |
Why?
|
| New York City | 1 | 2017 | 737 | 0.120 |
Why?
|
| New York | 1 | 2017 | 882 | 0.120 |
Why?
|
| Antibodies, Viral | 2 | 2024 | 3216 | 0.120 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2021 | 2596 | 0.120 |
Why?
|
| Immunoglobulin G | 2 | 2024 | 4568 | 0.110 |
Why?
|
| Patient Care Management | 1 | 2017 | 303 | 0.110 |
Why?
|
| Aortic Valve Insufficiency | 1 | 2018 | 577 | 0.110 |
Why?
|
| Postoperative Hemorrhage | 1 | 2017 | 419 | 0.110 |
Why?
|
| Anti-Retroviral Agents | 1 | 2023 | 1789 | 0.110 |
Why?
|
| Female | 10 | 2024 | 397192 | 0.100 |
Why?
|
| Prosthesis Failure | 1 | 2017 | 1208 | 0.100 |
Why?
|
| Receptors, Cell Surface | 1 | 2021 | 2819 | 0.100 |
Why?
|
| Viral Load | 1 | 2021 | 3396 | 0.100 |
Why?
|
| Male | 9 | 2024 | 364719 | 0.090 |
Why?
|
| Interleukin-6 | 1 | 2021 | 3228 | 0.090 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2022 | 1551 | 0.090 |
Why?
|
| Age Factors | 2 | 2017 | 18412 | 0.090 |
Why?
|
| Antigens, CD | 1 | 2021 | 4035 | 0.090 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2023 | 4415 | 0.090 |
Why?
|
| Humans | 13 | 2024 | 768166 | 0.090 |
Why?
|
| Middle Aged | 6 | 2024 | 223492 | 0.090 |
Why?
|
| Adult | 5 | 2024 | 223646 | 0.080 |
Why?
|
| Intubation, Intratracheal | 1 | 2016 | 1359 | 0.080 |
Why?
|
| Heart Arrest | 1 | 2017 | 1516 | 0.070 |
Why?
|
| Recovery of Function | 1 | 2017 | 2981 | 0.070 |
Why?
|
| Reoperation | 1 | 2017 | 4329 | 0.070 |
Why?
|
| Hemodynamics | 1 | 2017 | 4194 | 0.070 |
Why?
|
| Atherosclerosis | 1 | 2022 | 3433 | 0.070 |
Why?
|
| Adolescent | 3 | 2021 | 89169 | 0.060 |
Why?
|
| Follow-Up Studies | 2 | 2017 | 39348 | 0.060 |
Why?
|
| Retrospective Studies | 3 | 2021 | 81762 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2016 | 5315 | 0.060 |
Why?
|
| Survival Analysis | 1 | 2017 | 10101 | 0.060 |
Why?
|
| Young Adult | 2 | 2021 | 60066 | 0.050 |
Why?
|
| Databases, Factual | 1 | 2017 | 8080 | 0.050 |
Why?
|
| Treatment Outcome | 2 | 2017 | 65371 | 0.040 |
Why?
|
| Muscles | 1 | 2024 | 1582 | 0.040 |
Why?
|
| Incidence | 1 | 2017 | 21538 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2021 | 41754 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2017 | 24315 | 0.030 |
Why?
|
| Time Factors | 1 | 2017 | 40218 | 0.030 |
Why?
|
| Pregnancy | 1 | 2017 | 30256 | 0.030 |
Why?
|
| Infant | 1 | 2016 | 36535 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2016 | 42669 | 0.030 |
Why?
|
| Aged | 2 | 2021 | 171504 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 74944 | 0.020 |
Why?
|
| Child | 1 | 2016 | 80917 | 0.020 |
Why?
|
| Echocardiography | 1 | 2018 | 5047 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 59629 | 0.010 |
Why?
|